Guest

Signals accepts guest blog posts on topics relevant to stem cells and regenerative medicine, as well as submissions for its Right Turn Friday feature. See http://www.signalsblog.ca/about/ for more information. The opinions, accuracy, completeness and validity of any statements made in guest posts are the responsibility of the author only and not the editor of Signals or CCRM, publisher of Signals. The copyright of this content belongs to the author and any liability with regards to infringement of intellectual property rights remains with the author.

Posts by: Guest


Reimbursement – the final frontier

Author: Guest, 07/06/17

Patrick Bedford is the Senior Manager of Clinical Translation and Regulatory Affairs at CCRM. He holds a Master’s Degree in Bioethics and Health Law, and a Regulatory Affairs Certificate. Patrick has spent over 11 years applying federal regulations to emerging biotechnologies in Canada. Follow him on LinkedIN. Although I’m officially CCRM’s “regulatory guy,” I’ve been talking a…Read more

Right Turn: Beauty and brains – Disney updates inject STEM into classic tale

Author: Guest, 06/30/17

Malgosia Pakulska is the Communications and Development Officer at the Fields Institute for Research in Mathematical Sciences. She is also a science writer for Research2Reality, a blog designed to engage the public in Canadian research. Malgosia completed her PhD in Professor Molly Shoichet’s lab at the University of Toronto studying drug delivery systems for spinal cord regeneration…Read more

Five regenerative medicine workshops to attend this summer

Author: Guest, 05/15/17

Amin Adibi is a biomedical engineer and a health data analyst at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for…Read more

Funding the future: Highlights from Bloom Burton & Co.’s Healthcare Investor Conference

Author: Guest, 05/04/17

Samantha Yammine is a PhD Candidate in Dr. Derek van der Kooy’s lab at the University of Toronto studying how stem cells develop and maintain the brain. Samantha is passionate about science advocacy, policy, and education, and is an avid science communicator. You can find her sharing science straight from the lab on Instagram (@science.sam),…Read more

Improving ultrasound imaging may have applications in regenerative medicine

Author: Guest, 03/13/17

Andy Bell, a writer working with Toronto3dprinting, loves to write about different topics related to technological gadgets and gears. 3D printing is his current interest. Though ultrasound technology is commonly associated with the imaging of fetuses in the womb, its applications are much more than just imaging. The acoustic waves generated by ultrasound devices can…Read more

Cells…in a box

Author: Guest, 02/13/17

Heather Blumenthal has been writing about health and health research for more than 20 years and never loses her fascination with the advances Canadian researchers are making. You can reach her at hblumenthal@sympatico.ca It’s like magic – insert a cancer patient’s blood cells in one end and out the other end come T-cells adapted for…Read more

Peter Zandstra and CCRM: Making cell therapies a commercial reality

Author: Guest, 01/31/17

Dr. Rohin Iyer is currently a Development Manager at GE Healthcare / CCRM. He did his PhD in Biomedical Engineering at the University of Toronto, and has been working in the field of stem cells and tissue engineering for over 12 years. He is an avid tweeter (follow @DrRohinIyer) on cell therapies and regenerative medicine. …Read more

Right Turn: Every damn swan – a note on the scientific hypothesis

Author: Guest, 12/02/16

Malgosia Pakulska is a research associate in the Shoichet lab at the University of Toronto and a science writer for Research2Reality, a blog designed to engage the public in Canadian research. Malgosia wants to educate, entertain, and show people what science is really like, one story at a time. When she is not in the lab,…Read more

Insights from CGTW16 – Part 3: Clinical trials, health economics and regulatory affairs

Author: Guest, 12/01/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Insights from CGTW16 – Part 2: scale-up challenges and closed systems

Author: Guest, 11/23/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more